Literature DB >> 35677205

Does Cognitive Training Improve Mobility, Enhance Cognition, and Promote Neural Activation?

Uros Marusic1,2, Joe Verghese3,4, Jeannette R Mahoney3.   

Abstract

A close inter-relationship between mobility and cognition is reported in older adults, with improvements in gait performance noticeable after cognitive remediation in frail individuals. The aim of this study was to evaluate the efficacy of computerized cognitive training (CCT) on mobility in healthy, independently living older adults, and to determine whether CCT is associated with changes in neural activation for mobility-related brain processes. Using a randomized single-blind control design, sixty-three non-demented adults age 60 y and older (mean age = 67 y; 76% female, mean Montreal Cognitive Assessment [MoCA] score = 27) were recruited from a local Senior Activity Center. Participants were randomly assigned to either a 2-month CCT program (8 weeks, 3x/week, 40 min/session) or a wait-list control group. Primary outcome was self-selected gait speed during single- and dual-task walking. Secondary outcome was executive function on Trail Making Test (TMT), Part B. Neural activity was assessed via electroencephalography/event-related potentials (EEG/ERPs) targeting lower-limb performance. Results from a linear mixed effect model, adjusted for baseline MoCA score, age, gender, and study completion revealed that compared to controls, CCT improved gait speed during the dual-task (p = 0.008) but not during the single-task walking condition (p = 0.057). CCT also improved executive function (p = 0.024). Further, shorter foot reaction time responses (p = 0.019) were found with enhanced neural activation over sensorimotor areas, with shorter ERP latencies during the P2 component (p = 0.008) and enhanced motor responses (p = 0.009) also evident in the CCT group after the intervention. Overall, the electrophysiological findings suggest possible neural adaptations that could explain improvements in mobility and executive functions associated with CCT in healthy older adults.
Copyright © 2022 Marusic, Verghese and Mahoney.

Entities:  

Keywords:  cognitive-motor brain networks; executive control; functional mobility; healthy aging; motor-related cortical potentials (MRCP); sensorimotor integration; visual evoked potentials (VEP)

Year:  2022        PMID: 35677205      PMCID: PMC9168002          DOI: 10.3389/fnagi.2022.845825

Source DB:  PubMed          Journal:  Front Aging Neurosci        ISSN: 1663-4365            Impact factor:   5.702


Introduction

Walking difficulties are widespread among older adults, and are associated with restricted activities of daily living, mobility disability and death (Hirvensalo et al., 2000; Rosano et al., 2008). While exercise is recommended to improve mobility (Urzi et al., 2019), only 16% of U.S. seniors exercise at the recommended level and 33% remain inactive (Lee et al., 2017). Sedentary behavior or inactivity is related to increased risk of disability within all levels of physical activity (DiPietro et al., 2018). Among non-pharmacological interventions, cognitive training has been shown to stabilize or even improve cognitive performance of healthy older adults (Tardif and Simard, 2011; Simons et al., 2016). Gait and cognitive functions are interrelated in older adults. Previous studies have revealed that the prefrontal cortex (PFC) plays a critical role in successful gait and cognition (Beauchet et al., 2016) and have linked gait to structural changes in cerebellar, precuneus, supplementary motor, insular, and PFC brain regions (Blumen et al., 2019). These findings support the notion that cognitive training could improve both cognitive and motor functions. Additionally, previous experiments have shown that cognitive training can improve response times, with improvements seen in multiple ERP components in healthy young (Olfers and Band, 2018) and old adults (Gajewski and Falkenstein, 2012, 2018; Pergher et al., 2018), promoting neural enhancements in aging (Nguyen et al., 2019). Impairments in cognitive processes are associated with slower gait and gait instability (Montero-Odasso et al., 2012). Successful mobility performance is dependent on intact cognitive function (Montero-Odasso et al., 2012). Hence, recent research has focused on ways to improve cognitive function as a means to improve mobility. In a pilot study with sedentary seniors, Verghese et al. (2010) reported a far transfer computerized cognitive training (CCT) effect to mobility. A recent meta-analysis of 10 trials with 351 participants reported that cognitive training interventions can improve mobility-related outcomes, especially during challenging walking conditions requiring higher-order executive functions (Marusic et al., 2018a,b). More recently, computerized cognitive remediation improved walking and executive functions in older adults aged 70 years and above at high-risk for mobility disability, but not compared to an active control that included low level cognitive remediation training (Verghese et al., 2021). Most studies examining the effect of CCT on mobility-related outcomes enrolled sedentary or frail older adults (Verghese et al., 2010; Smith-Ray et al., 2013; Ng et al., 2015; Azadian et al., 2018), and demonstrate significant CCT effects on mobility outcomes. Although the association between brain health, cognition and mobility has been demonstrated even in non-clinical populations (Cohen et al., 2016; Demnitz et al., 2017), the effect of CCT in healthy active older adults has not been established. Moreover, the underlying neural mechanisms of enhanced gait control after cognitive remediation programs have not been well investigated (Marusic et al., 2018b). To address these knowledge gaps, we conducted a randomized single-blind control trial in 63 healthy active older adults. Our hypotheses were based on our previous work (Marusic et al., 2018a,b), which indicated that CCT would lead to improvements in executive functions and gait performance, particularly during challenging walking while talking conditions. We also hypothesized that CCT-related enhancements would be evident in pre-post assessments using electroencephalography (EEG)/event-related potentials (ERPs) over sensorimotor regions. This was guided by our recent investigation of the efficiency of recruitment of neuronal resources for the upper and lower extremity response task in young and old adults (Marusic et al., 2022), thus sparking an interest in investigating CCT related changes in neural activation.

Methods

Study Design

The current study employed a single-blind randomized control trial design to investigate the efficacy of computerized cognitive training (CCT) on gait in healthy older adults recruited from a local adult activity center in Koper, Slovenia (EU). The inclusion criteria were: active and healthy older adults (defined according to self-reported questionnaires), normal or corrected normal vision, and no self-reported history of cardiovascular, neurological, or psychiatric conditions. The exclusion criteria were: symptoms of cognitive decline or evidence of cognitive impairment on the Montreal cognitive assessment (MoCA; score < 25), history of falls in the past 12 months, regular heavy alcohol consumption, or presence of acute or chronic skeletal, neuromuscular, metabolic and/or cardiovascular disease conditions that may limit mobility. All procedures were carried out in accordance with the ethical standards of the 1964 Declaration of Helsinki and were approved by the Republic of Slovenia National Medical Ethics Committee (KME57/06/17). Written informed consent was obtained from all participants prior to study enrollment. The trial was registered at ClinicalTrials.gov (NCT03860441).

Participants

Figure 1 presents the study flow. From the initial 77 participants who were assessed for eligibility, 63 were randomized to either the intervention or the wait-list control group. Fourteen participants were excluded because they either did not meet study criteria or were unwilling to participate in the study. Sixty-three older participants (67.5 ± 5.9 years; MoCA score: 27.2 ± 1.7) were enrolled and included in the intention to treat analyses (see Figure 1). A subsample of 45 participants agreed to complete an EEG / ERPs study before and after the CCT intervention.
Figure 1

Study flow diagram. *A mixed linear model (MLM) analysis of variance was used for EEG sub-analysis when EEG data were of good quality and a merged pre-post EEG decomposition was acceptable. Poor quality of pre- or post-EEG data resulted in elimination of both datasets.

Study flow diagram. *A mixed linear model (MLM) analysis of variance was used for EEG sub-analysis when EEG data were of good quality and a merged pre-post EEG decomposition was acceptable. Poor quality of pre- or post-EEG data resulted in elimination of both datasets.

Clinical Assessments

Prior to the intervention, all participants were screened and interviewed by the research team. We asked participants to rate their general health on a 5-point Likert scale ranging from 1 (worst possible) to 5 (best). As previously mentioned, the MoCA (Nasreddine et al., 2005) was used to determine inclusion eligibility and also served as a covariate in the statistical models.

Computerized Cognitive Training Intervention

A commercially available internet-based cognitive training software CogniFit (CogniFit INC; San Francisco, CA, USA) was used for training. CogniFit software provides participants' with individualized training programs based on the results of their baseline cognitive performance evaluation. Difficulty of each cognitive task or game is systematically increased by the software in order to gradually increase the difficulty of each subsequent task, while ensuring that all abilities are trained. As well, this methodology is intended to provide personalized programs that strategically strengthen the individual's weakest cognitive abilities by emphasizing cognitive strengths in a manner that keeps participants within their comfort zone. The CCT training software in this study (CogniFit) is identical to that employed by Verghese et al. (2010, 2016, 2021) in their previous cognitive remediation trials. Participants in the CCT group attended 40 mins training sessions three times weekly for a total of 8 weeks (24 sessions). The length of each daily session was set according to optimal duration determined in our systematic review (Marusic et al., 2018b). Sessions were administered at the activity center. CCT sessions included a maximum of eight participants and a minimum of two research assistants who aided with software initiation and insured participants' comprehension of each CCT task instruction set.

Wait-List Control

Participants randomly allocated to the control group were informed that upon conclusion of baseline measurements, their name would be added to a wait-list for future studies at our center. They received a lecture detailing the importance of maintaining a healthy lifestyle. Research assistants contacted control participants weekly via telephone to maintain interest and adherence in the trial as well as to match for study contacts in the intervention arm. Participants in the wait-list group were not revealed to the intervention group participants, and vice versa as members of each group were invited to the activity center on different days and/or times.

Outcome Measures

Our primary outcome measure was gait speed (m/s) during single- and dual-task walking conditions. Our secondary outcomes included executive function performance as assessed with the Trail making test (TMT); a simple visual reaction time task with lower limb as part of the EEG study; as well as sensory and motor ERPs. Research assistants assessed all outcome measures blinded to study group allocation at baseline and immediately following the conclusion of the 8-week study period for both the intervention and control groups.

Single- and Dual-Task Walking

Gait speed in single and dual task conditions was selected as our primary outcome as it is the most widely used metric to characterize mobility, and it was demonstrated to be sensitive to CCT effects (Verghese et al., 2010). Participants were instructed to “walk as if they were going to the nearest store and they were not in any hurry.” Gait speed was acquired with the 2D OptoGait system (Microgate, Bolzano, Italy); a valid and reliable measure of gait (Lienhard et al., 2013). To measure steady-state gait, all participants started at a marked point on the floor 2 meters before the 5-meter OptoGait recording area, and then walked until they reached a marked point 2 meters beyond the recording area. To study cognitive-motor interactions, participants were instructed to walk at their preferred speed, while performing a cognitive interference task, which required them to recite alternate letters of the alphabet starting with the letter “A” (Verghese et al., 2010, 2016). They were instructed to pay equal attention to walking and talking to minimize task prioritization effects (Verghese et al., 2007). The number of errors and correctly recited alternate letters were recorded by the research assistants. Each participant completed a baseline practice trial of reciting alternate letters of the alphabet while standing prior to the dual-task walking.

Cognitive Measures

Executive function and attention are two essential cognitive resources required for normal walking (Montero-Odasso et al., 2012). The Trail Making Test (TMT) is divided into two parts and provides general information on visual search, scanning, speed of processing, mental flexibility, and executive function (Tombaugh, 2004). Part A assesses simple visual attention and sequencing (Reitan and Wolfson, 1985), while Part B assesses executive functions linked to prefrontal cortex activity (Kubo et al., 2008). Part B was strategically included to detect CCT-related transfer of learning (Marusic et al., 2018a).

Electrophysiological and Psychophysical Measures

Scalp electroencephalographic (EEG) activity was recorded using g.tec medical engineering equipment (Schiedlberg, Austria, EU), with 32 Ag/AgCl electrodes, arranged according to the International 10–20 System. The sampling rate was 512 Hz with 32-bit resolution. Due to time- and study resource-constrains, only a sub-group of 23 intervention and 22 control participants were randomly selected and measured before and after the 2-month study period (see Figure 1). Participants were assessed while seated in a neutral position. After collection of baseline measurements with eyes open and closed, participants were instructed to perform a simple reaction time test in response to 70 visual stimuli presented with a random inter-stimulus interval between 2 and 5 secs on a 17.0-inch flat panel LCD monitor (120-Hz refresh rate) situated ~50 centimeters in front of them. Their task was to press the response button as quickly as possible with the bottom of the right foot (which rested on the response pad). The response pad was connected to a trigger box (g.tec TRIGbox). The visual stimuli were presented in the center of a monitor (circular disc with a 5 cm radius was presented against a black background at the center of the display, duration 150 ms, intensity 50 cd/m2) placed directly in front of the participant's field of view. Stimulus-locked ERPs (s-ERPs; also known as visual-evoked potentials VEPs) and response-locked ERPs (r-ERP; for the lower limb, also known as motor-related cortical potentials MRCPs) were extracted as described in Yordanova et al. (2004). The s-ERPs correspond to occipital electrodes (averaged across O1, Oz, and O2) and show visual components P1, N1, and P2 after the visual stimuli occurrence while the r-ERPs (MRCP) correspond to central electrode Cz and show the peak latency and amplitude of the most negative displacement of the MRCP, prior to or at the time of response execution. Details about sensorimotor task and EEG/ERP processing can be found in manuscript of Marusic et al. (2022).

Statistical Analyses

Data were analyzed in SPSS software version 26.0 (IBM, Chicago, IL). An examination for normal distribution was conducted using the Shapiro-Wilk's test and visual inspection (histogram and Q-Q plot). To examine potential group differences in demographic and clinical outcome measures at baseline, an independent-sample t-test was performed. The difference between groups in attrition rate was assessed using chi-square statistics. A mixed linear model (MLM) analysis of variance was used to test the effect of the 2-month CCT intervention on the outcome measures in comparison with the control group. Groups were compared using the intention-to-treat principle with MLM adjusted for confounders (baseline MoCA score, age, and gender). While the MLM can handle missing data due to dropout missing at random (Laird and Ware, 1982), the analysis controlled for attrition in both arms by including a dichotomous ‘study completion' variable as a covariate in the model. More specifically, Group (experimental vs. control), time (pre- vs. post-intervention), and group × time interaction terms were treated as fixed effects and participants as a random effect. Maximum Likelihood (ML) was used to produce parameter estimates. The alpha level was set to 0.05.

Results

Group Characteristics

Of the 63 participants, 32 were randomized to the CCT and 31 to the control group. Table 1 represents the baseline characteristics of the final sample. The majority of participants were women (78% in CCT and 74% in control group); however, the two groups did not demonstrate significant differences across any key demographic variables suggesting adequate randomization. The sub-sample of 45 participants for EEG/ERP analysis also did not show any group differences in baseline characteristics (all ps ≥ 0.125).
Table 1

Table of baseline characteristics for intervention and control group (intention to treat).

Variables Intervention Control p value
N3231
Age (years)67.7 ± 5.867.2 ± 6.00.757
Women (n)2523
BMI (kg/m2)25.4 ± 5.325.8 ± 4.40.725
Education (years)13.4 ± 2.112.9 ± 2.10.294
MoCA score (0–30)27.4 ± 1.727.0 ± 1.70.353
General health status (1–5)*3.6 ± 0.63.7 ± 0.70.736
Self-selected gait speed ST(m/s)1.14 ± 0.211.18 ± 0.220.356
Self-selected gait speed DT (m/s)0.93 ± 0.250.95 ± 0.230.873
TMT A (sec)41.8 ± 19.746.6 ± 23.50.425
TMT B (sec)98.9 ± 50.199.2 ± 52.40.987

1, minimal; 5, best; BMI, body mass index; MoCA, Montreal Cognitive Assessment; TMT, Trail Making Test.

Table of baseline characteristics for intervention and control group (intention to treat). 1, minimal; 5, best; BMI, body mass index; MoCA, Montreal Cognitive Assessment; TMT, Trail Making Test. The attrition in the control group (n = 9) was significantly higher than the attrition in the intervention group (n = 3; (χ(1) = 3.946, p = 0.047). In the control group, 3 participants were lost due to medical issues and 6 participants did not show up for the POST measurement session. In the intervention group, 1 participant was lost due to medical issues and 2 participants discontinued the intervention program (see also Figure 1). There were no significant differences in baseline characteristics parameters between those who dropped vs. those who completed the study (p ≥ 0.217); however, we included study completeness as a covariate in the MLM. In the intervention group, the CCT adherence was high (87.3%). When queried about self-reported daily computer exposure, eight CCT participants (25.0%) reported daily computer exposure prior to the study, 12 (37.5%) reported moderate exposure, while the remaining 12 (37.5%) reported minimal to no computer exposure.

Primary Outcomes

Primary outcome results are presented in Table 2.
Table 2

Mixed-effect linear model results for primary outcome measures revealing Group, Time, and Group × time interactions as well as adjustments.

Parameter Estimate Std. error df t Sig. 95% confidence interval
Lower bound Upper bound
Self-selected single-task gait speed
Group * Time−0.0980.05048.222−1.9490.057−0.1990.003
Gender−0.0010.05847.871−0.0160.987−0.1180.116
Age−0.0020.00546.995−0.3320.741−0.0110.008
MoCA total score0.0080.01547.1220.5290.599−0.0230.039
Study completion−0.0360.07254.746−0.5000.619−0.1790.108
Self-selected dual-task gait speed
Group * Time−0.1300.04645.127−2.790 0.008 −0.223−0.036
Gender0.0160.07647.1560.2120.833−0.1360.168
Age−0.0070.00646.625−1.1240.267−0.0190.005
MoCA total score−0.0060.02046.516−0.3150.754−0.0460.034
Study completion−0.0650.09151.444−0.7140.479−0.2480.118

Significant group × time interactions are signed with bold.

Mixed-effect linear model results for primary outcome measures revealing Group, Time, and Group × time interactions as well as adjustments. Significant group × time interactions are signed with bold.

Self-Selected Single-Task Gait Speed

At baseline, no difference between group was observed for the self-selected single-task gait speed (p = 0.226). However, there was a non-significant group × time interaction trend (p = 0.057; Table 2). Post-hoc analyses revealed that self-selected gait speed significantly increased within the intervention group (+17.0 ± 21.3%; p <0.001), while there was a lesser within group improvement for the control group (+7.2 ± 15.4%; p = 0.096). Comparison of speed in the self-selected single-task gait speed condition showed that older adults in the intervention group walked 0.16 m/s faster at the end of the CCT intervention, whereas participants in the control group increased their speed by 0.07 m/s from baseline.

Self-Selected Dual-Task Gait Speed

At baseline, no difference between group was observed for the self-selected dual-task gait speed (p = 0.901). The MLM revealed a significant group × time interaction (p = 0.008) indicating that CCT improved dual-task performance in the intervention compared to the control group. Post-hoc analyses revealed that self-selected dual-task gait speed significantly increased within the intervention group (+20.6 ± 24.8%; p < 0.001), while there were no within group changes pre- to post-intervention for the control group (+3.0 ± 13.8%; p = 0.467). Older adults in the intervention group walked 0.13 m/s faster in self-selected dual-task gait speed condition at the end of the CCT intervention, whereas participants in the control group increased their speed by 0.02 m/s from baseline.

Secondary Outcomes

Secondary outcome results are presented in Table 3. We had reported blood draws as secondary outcomes in the clinicaltrials.gov registration form, but these are not included in this manuscript due to their complexity.
Table 3

Mixed-effect linear model results for secondary outcome measures revealing Group, Time and Group × time interactions as well as covariates.

Parameter Estimate Std. error df t Sig. 95% confidence interval
Lower bound Upper bound
TMT A
Group * Time6.9994.62544.0071.5130.137−2.32216.320
Gender−6.7465.80848.420−1.1610.251−18.4224.930
Age−0.1090.48450.718−0.2250.823−1.0820.864
MoCA total score−0.9861.51047.039−0.6530.517−4.0242.052
Study completion2.2697.29561.3070.3110.757−12.31716.855
TMT B
Group * Time28.06311.98142.7962.342 0.024 3.89852.227
Gender−19.07412.42646.818−1.5350.132−44.0755.926
Age0.6281.04249.9840.6030.550−1.4652.720
MoCA total score−8.2193.22045.026−2.5520.014−14.705−1.733
Study completion8.98416.05365.9650.5600.578−23.06741.034
Foot reaction times
Group * Time27.68511.03425.6412.509 0.019 4.98850.382
Gender17.64214.57233.3201.2110.235−11.99447.277
Age1.3991.10031.9221.2720.213−0.8423.639
MoCA total score−1.4083.99133.024−0.3530.727−9.5286.713
Study completion4.75515.36938.9740.3090.759−26.33235.841
Stimulus processing P1 amplitude
Group * Time1.3011.06918.5501.2180.239−0.9393.542
Gender1.6040.81722.2221.9620.062−0.0903.298
Age0.1350.07326.7471.8490.076−0.0150.285
MoCA total score−0.5560.22321.098−2.4930.021−1.020−0.092
Study completion−0.3111.19433.987−0.2600.796−2.7362.115
Stimulus processing P1 latency
Group * Time6.5589.86617.9000.6650.515−14.17727.294
Gender−11.8218.78823.016−1.3450.192−30.0006.357
Age0.6520.77226.5750.8450.406−0.9322.236
MoCA total score2.9472.40822.2561.2240.234−2.0447.938
Study completion1.55711.83931.4650.1320.896−22.57425.689
Stimulus processing N1 amplitude
Group * Time−1.1121.07316.109−1.0360.315−3.3851.161
Gender−1.6661.32923.356−1.2530.223−4.4141.082
Age−0.0890.11425.436−0.7820.441−0.3230.145
MoCA total score0.5780.36623.0071.5780.128−0.1801.335
Study completion−1.1601.42022.980−0.8170.423−4.0971.778
Stimulus processing N1 latency
Group * Time12.16012.51218.0910.9720.344−14.11738.438
Gender−11.12610.14522.389−1.0970.284−32.1449.892
Age0.1660.90026.5720.1850.855−1.6812.014
MoCA total score2.4002.77421.4150.8650.397−3.3628.161
Study completion6.38614.40033.4310.4430.660−22.89635.668
Stimulus processing P2 amplitude
Group * Time−0.8991.21814.437−0.7380.472−3.5051.706
Gender2.3301.49721.8131.5560.134−0.7775.437
Age−0.0390.12824.097−0.3020.765−0.3030.226
MoCA total score−0.3280.41221.433−0.7950.435−1.1840.528
Study completion1.3741.61021.5970.8540.403−1.9684.716
Stimulus processing P2 latency
Group * Time27.0128.65613.0463.121 0.008 8.32045.704
Gender−0.85113.85121.462−0.0610.952−29.61927.917
Age−1.7261.17322.911−1.4710.155−4.1530.702
MoCA total score−1.2343.82121.246−0.3230.750−9.1746.707
Study completion16.78711.94416.7521.4050.178−8.44242.016
Motor-related processes: peak amplitude
Group * Time−3.5011.20718.500−2.901 0.009 −6.032−0.971
Gender1.3801.27924.1861.0790.291−1.2594.018
Age0.0060.10923.4680.0590.953−0.2190.232
MoCA total score−0.0970.34224.113−0.2830.780−0.8020.609
Study completion1.9241.59630.9381.2060.237−1.3305.178
Motor-related processes: peak latency
Group * Time−0.54913.02314.251−0.0420.967−28.43527.337
Gender−3.47713.64020.750−0.2550.801−31.86424.909
Age−2.0261.64219.614−1.2330.232−5.4561.405
MoCA total score−2.9713.66920.245−0.8100.428−10.6184.677
Study completion−7.62917.60815.684−0.4330.671−45.01729.759
Motor-related processes: onset latency
Group * Time−19.04921.21514.570−0.8980.384−64.38526.287
Gender5.53516.21217.7920.3410.737−28.55539.624
Age−1.1081.98616.088−0.5580.584−5.3163.099
MoCA total score−5.7274.36817.060−1.3110.207−14.9413.488
Study completion9.18825.81616.6830.3560.726−45.35863.735

Significant group × time interactions are signed with bold.

Mixed-effect linear model results for secondary outcome measures revealing Group, Time and Group × time interactions as well as covariates. Significant group × time interactions are signed with bold.

TMT A

At baseline, no difference between groups was observed in TMT A test (p = 0.397). The MLM revealed no significant group × time interaction (p = 0.137). Delta values showed that post-CCT, older adults in the intervention group solved TMT A, on the average, 9.8 s faster compared to older adults in the control group who solved TMT A, on the average, 2.5 s faster.

TMT B

At baseline, no difference between groups was observed in TMT B test (p = 0.948). The MLM revealed a significant group × time interaction (p = 0.024). Post-hoc analyses revealed that time to complete the TMT B was significantly reduced in the intervention group (−21.1 ± 31.1%; p = 0.002), while there were no changes pre- to post-intervention for the control group (+2.9 ± 33.0%; p = 0.855). Delta values showed that older adults in the intervention group solved TMT B on average 31.9 s faster at the end of the CCT intervention, whereas participants in the control group reduced solving time by 1.3 s.

Foot Reaction Time Test

At baseline, no difference between groups was observed in simple reaction time using lower limbs (p = 0.932). However, the MLM revealed a significant group × time interaction (p = 0.019). Post-hoc analyses revealed that simple reaction time was significantly reduced in the intervention group (−5.0 ± 9.9%; p = 0.040), however remained unchanged in the control group (+2.7 ± 9.4%; p = 0.222) during the pre- to post-intervention period. Delta values showed that older adults in the intervention group had on average foot reaction time 9.5 ms faster at the end of the CCT intervention, whereas participants in the control group prolonged their foot reaction time on average by 6.8 ms.

ERPs

Results for the ERP components are summarized in Figures 2, 3 and Table 2. A significant interaction between group and time was found for the P2 latency component (p = 0.008). Post-hoc analyses revealed that P2 latency was significantly reduced in the intervention group (−6.6 ± 5.7%; p < 0.001; Figure 2 left), there were no changes pre- to post-intervention for the control group (+1.8 ± 9.1%; p = 0.500). Delta values revealed that older adults in the intervention group reduced their P2 latency on average for 14.6 ms at the end of the CCT intervention, whereas participants in the control group prolonged their P2 latency by 4.0 ms.
Figure 2

Grand average stimulus-locked event-related potentials (s-ERPs) for the intervention (left) and control (right) group. Figure represents the grand averaged ERPs for pre- (gray, solid) and post-assessments (red, dashed) for intervention (left) and control group (right). The s-ERPs correspond to occipital electrodes (averaged across O1, Oz, and O2) and show visual components P1, N1 and P2 after the visual stimuli occurrence.

Figure 3

Grand average response-locked event-related potentials (r-ERPs) for the intervention (left) and control (right) group. Figure represents the grand averaged ERPs for pre- (gray, solid) and post-assessments (red, dashed) for intervention (left) and control group (right). The r-ERPs (MRCP) correspond to central electrode Cz and show the peak latency and amplitude of the most negative displacement of the MRCP, prior to or at the time of response execution.

Grand average stimulus-locked event-related potentials (s-ERPs) for the intervention (left) and control (right) group. Figure represents the grand averaged ERPs for pre- (gray, solid) and post-assessments (red, dashed) for intervention (left) and control group (right). The s-ERPs correspond to occipital electrodes (averaged across O1, Oz, and O2) and show visual components P1, N1 and P2 after the visual stimuli occurrence. Grand average response-locked event-related potentials (r-ERPs) for the intervention (left) and control (right) group. Figure represents the grand averaged ERPs for pre- (gray, solid) and post-assessments (red, dashed) for intervention (left) and control group (right). The r-ERPs (MRCP) correspond to central electrode Cz and show the peak latency and amplitude of the most negative displacement of the MRCP, prior to or at the time of response execution. Similarly, a significant interaction was found for the peak amplitude in motor-related processes (p = 0.009). Post-hoc analyses revealed that MRCP peak amplitude was significantly reduced in the intervention group (−14.5 ± 23.3%; p = 0.029; Figure 3 left), though there were no changes pre- to post-intervention for the control group (+22.6 ± 47.7%; p = 0.154). Delta values indicated that older adults in the intervention group reduced their MRCP peak amplitude on average for 1.1 uV at the end of the CCT intervention, whereas participants in the control group increased their MRCP peak amplitude by 0.2 uV. No other significant interactions were found for the remaining ERP components (see Table 3).

Correlation Analyses

There were significant correlations found only in the Intervention group between delta scores on TMT B and self-selected dual-task gait speed (r = −0.42; p = 0.041), TMT B and P2 latency (r = 0.62; p = 0.025), and self-selected dual-task gait speed and P2 latency (r = −0.68; p = 0.006).

Discussion

The findings from this single-blind randomized controlled trial reveal that CCT was effective in improving not only gait but also executive function in active, healthy and independently living older adults. At the conclusion of this structured 2-month cognitive training program (24 sessions of CCT), the intervention group exhibited improved gait performance, especially during challenging walking conditions, relative to the control group. Enhanced primary/gait outcome measures were accompanied with enhanced performance on a test of executive function (TMT) as well as on a sensorimotor task for lower limbs. This was also evident from a correlation analysis showing that improvements in motor and cognitive functions were related to a shortening of the P2 component of visual processing. To our knowledge, this is the first study to reveal that CCT alone can improve complex mobility performance in active, healthy older adults. These results extend previous behavioral reports of the impact of CCT on both cognitive and motor performance in less healthy populations (Mewborn et al., 2017; Marusic et al., 2018b), as well as provide preliminary support for neural enhancements in the aging brain. The improvement in executive functions in the intervention group supports near transfer of training effects of CCT as demonstrated in previous studies (Klusmann et al., 2010; Heinzel et al., 2014; Marusic et al., 2018a). Compared to the controls, participants in the intervention group required less time to complete the TMT B task - a test of executive functioning that was not used for training purposes in the CogniFit software. Also, the TMT was administered only twice (both pre- and post- study) to both the intervention and control groups, so practice effects across both groups cannot explain enhancements in performance solely for the intervention group. Traditionally, training interventions have only evaluated cognitive training-related improvements in the directly trained cognitive domain (Butler et al., 2018), although some initial cognitive interventions report potential transfer effects to other domains like driving performance and daily functioning (Ball et al., 2002; Willis et al., 2006). Far transfer, to a distal untrained domain, such as mobility was reported in the present trial in a sample of asymptomatic older adults where self-selected dual-task gait speed was significantly increased (0.13 m/s = 21% intervention vs. 0.02 m/s = 3% control improvement) in the intervention compared to control group. Moreover, there was a trend toward improved walking speed during the single-task (0.16m/s = 17% intervention vs. 0.07m/s = 7% control improvement). Similar findings were obtained in a pilot study of sedentary older adults (Verghese et al., 2010) and latter summarized in our meta-analytical review (Marusic et al., 2018b) that highlighted larger cognitive training-related improvements during challenging walking conditions given their reliance on higher-order executive functions. From the perspective of clinically meaningful change, both gait speeds were increased by more than 0.08 m/s in the intervention group, which was considered a meaningful change in physical performance (Kwon et al., 2009). Recently, a larger CCT study of 383 non-demented seniors at high risk for mobility disability was completed (Verghese et al., 2021). The authors reported an improvement in walking, but this was no greater than in the active control group, who also completed the same amount of CCT but with no progress in the difficulty of the games performed (Verghese et al., 2021). Here, the authors report that practice effects might explain the improvements seen in both arms and the lack of between-group differences; however, the investigators also discuss an alternate hypothesis that the more robust effect on executive function tests in the cognitive remediation arm compared to the active control may indicate a true training effect, and raises the possibility that even low levels of cognitive remediation (as in their active control arm) lead to cognitive benefits (Verghese et al., 2021). Nevertheless, the current study differed in several ways that might explain the discrepancy in results including, smaller sample size, use of healthy elderly population, wait list control, and the inclusion of neurophysiological measures that were lacking in the previous trial. The near and far transfer improvements in the current experiment suggest that common brain substrates involving cognitive and mobility processes were strengthened by the CCT. The electrophysiological study in a subgroup of our participants provides further insights into the observed benefits. That is, the intervention group manifested shortened foot reaction times to visual stimuli after 2 months of CCT with concomitant P2 latency reduction over occipital regions as well as decreased MRCP amplitudes over motor cortex region. The former likely reflects enhancements in executive attention processes and sensory encoding (Finnigan et al., 2011), while the latter points toward the optimization in response generation and efficiency in depolarization of motor cortex neurons (Yordanova et al., 2004). While slower foot reaction times have been associated with falls (Lord et al., 2003), a recent study revealed a link between participation in cognitive activities and neuromotor performance (Cai et al., 2020). Although using a cross-sectional design, the latter study showed the participation in cognitively stimulating activities is associated with shorter foot reaction times and faster gait speed (Cai et al., 2020), which is consistent with our longitudinal observations. Enhancing neural substrates and consequently (sub)components of executive functions [i.e., cognitive flexibility; for details see (Diamond, 2013)] seems like a plausible explanation for improvements in gait (Marusic et al., 2018b), as well as sensory functioning. Previous EEG/ERP studies typically report a u-shape pattern in ERP components (Reuter et al., 2019), and more specifically increased P2 component latencies in older as compared to younger adults (Goodin et al., 1978; Iragui et al., 1993). Our recent study found overall larger amplitudes with delayed latencies of endogenous potentials in older compared to younger adults (Marusic et al., 2022), which is consistent with our recent findings in which P2 latency was significantly reduced after CCT. Moreover, the lower MRCP amplitude during sensorimotor task performed with the lower limbs may indicate less intense depolarization of motor cortex neurons or more efficient recruitment of neuronal resources required for the lower extremity response task after CCT (Yordanova et al., 2004; Marusic et al., 2022). It is well-documented that walking, a rhythmic motor task, involves complex motor, sensory and cognitive processes (Holtzer et al., 2006; Scherder et al., 2007; Al-Yahya et al., 2011). It is also known that older adults require more attentional demands for motor control while walking, indicating the compounded involvement of attentional resources during gait (Kressig, 2010). Moreover, the association of multisensory integration processes with attention-based performance (Mahoney and Verghese, 2020) and measures of mobility including balance, falls and gait (Mahoney et al., 2019) have been well established. Findings reveal that better performance on a visual-somatosensory simple RT test requiring lower limb responses was associated with better cognitive and motor outcomes in healthy older adults. The authors present a potential overlapping neural circuit which emphasizes the critical role of the prefrontal cortex for intact multisensory, motor and cognitive performance (Mahoney and Verghese, 2020). However, further studies are needed to determine whether CCT simultaneously improves sensory, cognitive, and motor functioning by targeting neural networks with connections to prefrontal cortex. The main strength of the current study is the application of a randomized control design for examining the effect of CCT. The current study replicates previous studies addressing mobility-related improvements after non-physical training, while revealing the potential of CCT in asymptomatic older adults and highlighting for the first time associated neural alterations. This study is not without limitations. The sample size was determined by convenience in which we targeted recruitment of older adults attending the Center for daily activities for the elderly. There was a relatively high attrition rate, particularly in the control group, but similar to other cognitive training studies (Ballesteros et al., 2014; Maffei et al., 2017). Attrition rates could likely be improved by including an active control group and/or compensating participants for their time and effort (Verghese et al., 2016). Recent findings by Verghese et al. (2021) in which the active control group showed cognitive and motoric benefits point to the possibility that even low levels of cognitive training have cognitive benefits (Verghese et al., 2021). We were unable to assess durability effects of CCT over time on our outcome measures. Future studies should explore monitoring brain activity directly during actual locomotion through a Mobile Brain/Body Imaging (MoBI) setup for example, to gain further insights into neuroplasticity in ecologically valid environments (Wunderlich et al., 2021).

Conclusions and Implications

Overall, results from the current study provide evidence that CCT improves mobility in a population of active, healthy and independently living older adults, and is associated with enhancements in cognitive performance. Enhanced executive functions together with optimization of sensorimotor processing that contributes to shorter lower-limb response times after CCT may play a role in enhanced mobility but requires further validation. Our correlational analyses suggest that neurophysiological findings support alterations in neural activity that may contribute to the reported enhancements in cognitive and motor performance. Understanding the underlying mechanisms of how non-physical interventions can improve mobility could guide future research in situations where physical exercise is limited or not possible such as before or after surgery or during periods of immobilization as in hospital stays. There is a need for well-designed large-scale clinical trials with active controls to identify neuronal substrates that are susceptible to CCT enhancement to improve current multimodal interventions to prevent cognitive and motoric declines in aging.

Data Availability Statement

Raw data supporting the results of this study are available from the corresponding author, upon reasonable request.

Ethics Statement

All procedures were carried out in accordance with the ethical standards of the 1964 Declaration of Helsinki and were approved by the Republic of Slovenia National Medical Ethics Committee (KME57/06/17).

Author Contributions

UM: concept creation, project holder, data acquisition monitoring, data processing, data analysis, interpretation of data, and drafted manuscript. JV and JRM: concept creation, interpretation of data, critically reading, and proof-reading the manuscript. All authors read and approved the final manuscript.

Funding

This study was supported by Slovenian Research Agency (research core Funding No. P5-0381) and European Social Fund and Ministry of Education, Science and Sport (Slovenia, EU). The authors also acknowledge financial support from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 952401 (TwinBrain – TWINning the BRAIN with machine learning for neuro-muscular efficiency).

Conflict of Interest

JRM has a financial interest in JET Worldwide Enterprises Inc., a digital health startup spun out of research conducted at Albert Einstein College of Medicine and such interest is not related to the current study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
  46 in total

1.  Long-term effects of cognitive training on everyday functional outcomes in older adults.

Authors:  Sherry L Willis; Sharon L Tennstedt; Michael Marsiske; Karlene Ball; Jeffrey Elias; Kathy Mann Koepke; John N Morris; George W Rebok; Frederick W Unverzagt; Anne M Stoddard; Elizabeth Wright
Journal:  JAMA       Date:  2006-12-20       Impact factor: 56.272

2.  Cognitive and neural plasticity in old age: A systematic review of evidence from executive functions cognitive training.

Authors:  Lan Nguyen; Karen Murphy; Glenda Andrews
Journal:  Ageing Res Rev       Date:  2019-05-30       Impact factor: 10.895

3.  Cognitive-Based Interventions to Improve Mobility: A Systematic Review and Meta-analysis.

Authors:  Uros Marusic; Joe Verghese; Jeannette R Mahoney
Journal:  J Am Med Dir Assoc       Date:  2018-04-19       Impact factor: 4.669

4.  Mobility difficulties and physical activity as predictors of mortality and loss of independence in the community-living older population.

Authors:  M Hirvensalo; T Rantanen; E Heikkinen
Journal:  J Am Geriatr Soc       Date:  2000-05       Impact factor: 5.562

5.  What is a meaningful change in physical performance? Findings from a clinical trial in older adults (the LIFE-P study).

Authors:  S Kwon; S Perera; M Pahor; J A Katula; A C King; E J Groessl; S A Studenski
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

6.  Computerized cognitive training during physical inactivity improves executive functioning in older adults.

Authors:  Uros Marusic; Bruno Giordani; Scott D Moffat; Mojca Petrič; Petra Dolenc; Rado Pišot; Voyko Kavcic
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2016-12-12

Review 7.  Gait and cognition: a complementary approach to understanding brain function and the risk of falling.

Authors:  Manuel Montero-Odasso; Joe Verghese; Olivier Beauchet; Jeffrey M Hausdorff
Journal:  J Am Geriatr Soc       Date:  2012-10-30       Impact factor: 5.562

8.  Age-related variations in evoked potentials to auditory stimuli in normal human subjects.

Authors:  D S Goodin; K C Squires; B H Henderson; A Starr
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1978-04

9.  Mobility and Upright Posture Are Associated with Different Aspects of Cognition in Older Adults.

Authors:  Rajal G Cohen; Anita N Vasavada; Michelle M Wiest; Maureen Schmitter-Edgecombe
Journal:  Front Aging Neurosci       Date:  2016-11-08       Impact factor: 5.750

10.  N-back training and transfer effects revealed by behavioral responses and EEG.

Authors:  Valentina Pergher; Benjamin Wittevrongel; Jos Tournoy; Birgitte Schoenmakers; Marc M Van Hulle
Journal:  Brain Behav       Date:  2018-10-23       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.